Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

C3a anticorps

C3a Reactivité: Humain WB Hôte: Souris Monoclonal 474 unconjugated
N° du produit ABIN2191943
  • Antigène Voir toutes C3a Anticorps
    C3a (Complement Fragment 3a (C3a))
    Reactivité
    • 13
    • 5
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 8
    • 6
    • 4
    • 2
    Souris
    Clonalité
    • 10
    • 10
    Monoclonal
    Conjugué
    • 14
    • 4
    • 1
    • 1
    Cet anticorp C3a est non-conjugé
    Application
    • 14
    • 7
    • 5
    • 4
    • 4
    • 4
    • 1
    • 1
    Western Blotting (WB)
    Stérilité
    0.2 μm filtered
    Clone
    474
    Top Product
    Discover our top product C3a Anticorps primaire
  • Indications d'application
    For Western blotting dilutions to be used depend on detection system applied. It is recommended that users test the reagent and determine their own optimal dilutions. The typical starting working dilution is 1:50. For functional studies, in vitro dilutions have to be optimized in user's experimental setting. Positive Human serum control Negative Serum of C3 deficient patients control 1
    Restrictions
    For Research Use only
  • Buffer
    PBS, containing 0.1 % bovine serum albumin and 0.02 % sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C
    Stockage commentaire
    Product should be stored at 4 °C. Under recommended storage conditions, product is stable for at least one year. The exact expiry date is indicated on the label.
  • Shi, Zhang, Wu, Feng, Li, Xie, Xue, Cai, Cui, Chen, Hou, Zhang, Yang: "Discovery and identification of potential biomarkers of pediatric acute lymphoblastic leukemia." dans: Proteome science, Vol. 7, pp. 7, (2009) (PubMed).

    Li, Chen, Tu, Zhao, Zhou, Li, Dai, Li, Nie, Li, Jia, Zeng, Wu: "Localized-statistical quantification of human serum proteome associated with type 2 diabetes." dans: PLoS ONE, Vol. 3, Issue 9, pp. e3224, (2008) (PubMed).

    Stöve, Klos, Bautsch, Köhl: "Re-evaluation of the storage conditions for blood samples which are used for determination of complement activation." dans: Journal of immunological methods, Vol. 182, Issue 1, pp. 1-5, (1995) (PubMed).

    Hartmann, Lübbers, Casaretto, Bautsch, Klos, Köhl: "Rapid quantification of C3a and C5a using a combination of chromatographic and immunoassay procedures." dans: Journal of immunological methods, Vol. 166, Issue 1, pp. 35-44, (1993) (PubMed).

  • Antigène
    C3a (Complement Fragment 3a (C3a))
    Autre désignation
    c3/c3a (C3a Produits)
    Synonymes
    anticorps AHUS5, anticorps ARMD9, anticorps ASP, anticorps C3a, anticorps C3b, anticorps CPAMD1, anticorps AI255234, anticorps HSE-MSF, anticorps Plp, anticorps C3d, anticorps complement C3, anticorps complement component 3, anticorps C3
    Sujet
    Monoclonal antibody 474 reacts with an epitope on C3a. The antibody reacts both with intact C3 as with C3a. The complement system is an important factor in innate immunity. The third complement component, C3, is central to the classical, alternative and lectin pathways of complement activation. The synthesis of C3 is tissue-specific and is modulated in response to a variety of stimulatory agents. During complement activation, C3 is proteolytically cleaved resulting in release of the anaphylatoxic peptide C3a. C3a is a small polypeptide consisting of 74 amino acids (ca.10 kDa). C3a itself is very short-lived and in serum cleaved rapidly into the more stable C3a-desArg (also called acylation stimulating protein, ASP) . C3a exerts its function through a specific receptor (C3aR), which belongs to the G-protein coupled receptor family. Expression of C3aR has been reported in many cell types including myeloid and non-myeloid cells. Expression of C3aR on haematopoietic stem/progenitor cells has been shown to promote the trafficking/homing of these cells to the BM. Engagement of C3aR on DCs and T cells has been shown to up-regulate these cell functions. C3a is a mediator of local inflammatory processes. It induces smooth muscle contraction, increases vascular permeability, and causes histamine release from mast cells and basophilic leukocytes. C3a is involved in inflammatory reactions seen in gram-negative bacterial sepsis, trauma, ischemic heart disease, post-dialysis syndrome and a variety of autoimmune diseases. An inherited deficiency of C3 predisposes the person to frequent assaults of bacterial infections. In ulcerative colitis, and idiopathic chronic inflammatory bowel disease, the deposition of C3 in the diseased mucosa has been reported. Aliases Complement component 3 Immunogen C3a
    Pathways
    Système du Complément
Vous êtes ici:
Support technique